Jaguar Health (JAGX) Other Non-Current Assets (2015 - 2026)

Jaguar Health's (JAGX) quarterly Other Non-Current Assets came in at $2.8 million in Q1 2026, up 106.83% year-on-year from $1.3 million in Q1 2025, and up 463.97% on a QoQ basis from $494000.0 in Q4 2025.

Jaguar Health (JAGX) Other Non-Current Assets (2015 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 12 years of Other Non-Current Assets data on file, last reported at $2.8 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 106.83% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a 106.83% increase from a year earlier, with the FY2025 full-year figure at $494000.0, down 63.35% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $2.8 million, up from $494000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for JAGX reached as high as $2.8 million in Q1 2026 and fell as low as $275000.0 in Q1 2024.
  • Historically, Other Non-Current Assets has averaged $1.1 million across 5 years, with a median of $1.0 million in 2023.
  • Across the five-year window, Other Non-Current Assets soared 2247.37% in 2022 and slumped 72.83% in 2024, its largest moves.
  • Year by year, Other Non-Current Assets stood at $995000.0 in 2022, then increased by 1.71% to $1.0 million in 2023, then surged by 33.2% to $1.3 million in 2024, then sank by 63.35% to $494000.0 in 2025, then soared by 463.97% to $2.8 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.8 million in Q1 2026, $494000.0 in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Nanobiotix 1,774.59 Bn 1,774.53 Bn - -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - 60,000.00
3 BeOne Medicines 473.53 Bn 468.74 Bn 1.35 Bn 104.24 Mn
4 Vertex Pharmaceuticals 123.91 Bn 116.66 Bn 2.59 Bn 1.26 Bn
5 Regeneron Pharmaceuticals 71.79 Bn 63.04 Bn 3.31 Bn 2.13 Bn
6 Belite Bio 62.15 Bn 62.15 Bn - 289.41 Mn
7 Argenx Se 54.75 Bn 49.57 Bn 1.41 Bn 124.00 Mn
8 Alnylam Pharmaceuticals 38.10 Bn 35.10 Bn 959.66 Mn 63.55 Mn
9 Revolution Medicines 36.11 Bn 36.11 Bn - 14.48 Mn
10 Jaguar Health 509,443.80 -9.55 Mn 19.11 Mn 2.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.79 Mn
Dec 31, 2025 494,000.00
Sep 30, 2025 1.24 Mn
Jun 30, 2025 1.24 Mn
Mar 31, 2025 1.35 Mn
Dec 31, 2024 1.35 Mn
Sep 30, 2024 1.34 Mn
Jun 30, 2024 276,000.00
Mar 31, 2024 275,000.00
Dec 31, 2023 1.01 Mn
Sep 30, 2023 1.01 Mn
Jun 30, 2023 1.01 Mn
Mar 31, 2023 1.01 Mn
Dec 31, 2022 995,000.00
Sep 30, 2022 1.84 Mn
Jun 30, 2022 1.75 Mn
Mar 31, 2022 446,000.00
Dec 31, 2021 446,000.00
Mar 31, 2021 19,000.00
Dec 31, 2020 37,000.00